XSHE300920
Market cap246mUSD
Dec 25, Last price
17.42CNY
1D
-0.94%
1Q
31.27%
IPO
-56.63%
Name
Zhejiang Runyang New Material Technology Co Ltd
Chart & Performance
Profile
Zhejiang Runyang New Material Technology Co., Ltd. engages in the research and development, production, and sale of polyolefin foam materials in China and internationally. It offers electron irradiation cross-linked polyethylene (IXPE), including antibacterial enhanced series, popular series, and special series. The company's IXPE products are used as high-performance basic materials; and other products are used in home building decoration, car interior, baby products, sports and leisure, consumer electronics, household appliances, medical equipment, and other industries. Zhejiang Runyang New Material Technology Co., Ltd. was founded in 2012 and is based in Hangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 359,265 -7.81% | 389,705 -22.29% | 501,502 15.52% | |||||||
Cost of revenue | 298,938 | 350,726 | 373,102 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 60,327 | 38,979 | 128,400 | |||||||
NOPBT Margin | 16.79% | 10.00% | 25.60% | |||||||
Operating Taxes | 5,224 | 25,317 | ||||||||
Tax Rate | 13.40% | 19.72% | ||||||||
NOPAT | 60,327 | 33,755 | 103,082 | |||||||
Net income | 42,054 25.66% | 33,466 -62.84% | 90,070 -29.05% | |||||||
Dividends | (1,285) | (80,000) | (40,000) | |||||||
Dividend yield | 0.06% | 5.15% | 1.17% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 14,176 | 114,833 | 92,592 | |||||||
Long-term debt | 1,389 | 168 | 2,669 | |||||||
Deferred revenue | 26,097 | 26,097 | 22,317 | |||||||
Other long-term liabilities | 26,097 | 1 | ||||||||
Net debt | (461,329) | (486,888) | (556,671) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 24,706 | 79,495 | 58,548 | |||||||
CAPEX | (67,331) | |||||||||
Cash from investing activities | (67,015) | |||||||||
Cash from financing activities | (83,577) | |||||||||
FCF | (11,227) | (7,325) | (78,809) | |||||||
Balance | ||||||||||
Cash | 476,894 | 601,403 | 631,267 | |||||||
Long term investments | 486 | 20,665 | ||||||||
Excess cash | 458,931 | 582,404 | 626,857 | |||||||
Stockholders' equity | 479,459 | 466,864 | 508,579 | |||||||
Invested Capital | 765,950 | 830,765 | 771,036 | |||||||
ROIC | 7.56% | 4.21% | 13.65% | |||||||
ROCE | 4.93% | 3.07% | 9.99% | |||||||
EV | ||||||||||
Common stock shares outstanding | 100,128 | 100,000 | 100,000 | |||||||
Price | 21.05 35.54% | 15.53 -54.46% | 34.10 -12.29% | |||||||
Market cap | 2,107,691 35.72% | 1,553,000 -54.46% | 3,410,000 -12.29% | |||||||
EV | 1,661,819 | 1,066,112 | 2,853,329 | |||||||
EBITDA | 100,605 | 71,399 | 151,696 | |||||||
EV/EBITDA | 16.52 | 14.93 | 18.81 | |||||||
Interest | 1,552 | 4,345 | 6,087 | |||||||
Interest/NOPBT | 2.57% | 11.15% | 4.74% |